Skip to main content

Table 2 Clinical demographics of study cohort, by group

From: Survey of transfemoral amputee experience and priorities for the user-centered design of powered robotic transfemoral prostheses

Variable

Overall (N = 114)

NMPK (n = 45)

n (%)**

MPK (n = 69)

p*

Amputation etiology

 Traumatic

90 (78.9%)

27 (60%)

63 (91.3%)

 < 0.001

 Non-traumatic (NT)

24 (21.1%)

18 (40%)

6 (8.7%)

  NT—dysvascular (diabetic)

7 (6.1%)

6 (13.3%)

1 (1.4%)

  NT—cancer

8 (7.0%)

5 (11.1%)

3 (4.3%)

  NT—congenital deformities

3 (2.6%)

2 (4.4%)

1 (1.4%)

  NT—surgical complications & infections (secondary)

6 (5.3%)

4 (8.9%)

2 (4.4%)

Gender

 Men

88 (77.2%)

30 (66.7%)

58 (84.1%)

0.011

 Women

22 (19.3%)

14 (31.1%)

8 (11.6%)

  

Med (IQR)

  

Age (a)

50 (15)

51 (22)

49.5 (13)

0.610

Age at amputation (a)

30 (22.5)

39 (31.5)

29 (21)

0.001

Time since amputation (a)

16.5 (26.3)

4.5 (19)

19.5 (26.8)

 < 0.001

Time from amputation to 1st TFP (mo.s)

6 (5)

6 (5.25)

6 (4)

0.760

  1. *Reported p-values for significant differences in distribution between NMPK and MPK user groups, using Pearson chi-squared test for categorial parameters (gender, etiology) and from Mann–Whitney U-test for all others. Significant differences highlighted in bold. **Subtotals less than 100% are due to individual missing responses